Saturday, February 27, 2010
These are the options?
Monday, February 8, 2010
The Future of ICD's?

- Fluoroscopy is not required intraop
- risk of complications such as pneumothorax, hemothorax, myocardial perforation and lead dislodgement are completely removed
- No introduction into the vascular system - especially useful in pediatric patients and patients with difficult or not vascular patentcy
- No risk of SVC vein occlusion or need for possible laser lead extraction for subsequent lead revision
- lower risk of lead dislodgement
These risks are minimized or bypassed due to the fact that the lead system is implanted entirely subcutaneously. The defibrillation coil runs parallel to the left aspect of the sternum and the lead body is then tunneled along (approximately) the 6th intercostal space to the device which is implanted parasternally (approximately 5 inches inferior to traditional placement and slighly more lateral).
The initial experiences that were reported described a virtually equivalent tolerance to alternate device placement, and not perceived increased patient discomfort when compared with traditional placement. DFT's were also successful at 65 joules or less allowing for a safety margin of at least 15J, given the devices maximum output at ~80 joules. This method of course is contraindicated in those who DO have an underlying pacing indication. That being said, the investigators did note that success of the post-shock pacing at higher than traditional values.
I personally am cautiously optimistic about the early success of this approach to implantation. I would like to see how the lead behaves chronically while it is in perpetual contact with subcuticular tissue. How will the leads perform chronically? How (if at all) will lead maturation manifest? Can the defibrillation coil become indurated with scar tissue? Will weight changes or either a decrease or increase in fat affect DFT's? How will that impact the leads efficacy? Only time will tell.
Discuss...
Wednesday, February 3, 2010
Arrhythmia Device Follow-up 101
It may sound a tad hokey but the greatest tool (usually) you have in your arsenal for following and troubleshooting CRM's is definitely your patient. Unless the patient is clearly a veterinary historian or otherwise inclined to vague and non-specific symptom relation, they are your best jumping off point. I can illustrate this with a very good example I recently encountered. A patient of mine, Mr. P, came to clinic for his annual check up. His original implant indication was sick sinus syndrome and for the past 5 years has had a total pacing percentage of no more than <0.1%.>30 bpm. He indeed after 5 years of almost no pacing, became fully pacemaker dependent. This is not an unusual occurrence as ~15-25% of SSS patients will develop varying degrees of AV block.
Mr. P was programmed to a rate responsive mode with a conservative rate response curve and performed a hall walk. In comparison with his marked shortness of breath walking 20 feet from the waiting room to the clinic versus the hallwalk totalling 60 feet, he was totally relieved of his symptoms with the new parameters.
I was quite lucky to have such a diligent and observant patient to aid me in programming his appropriately. More often than not, you will be met with stoicism or vague reporting of symptoms and parameters will by and large become trial and error.
The take home message here is listening to your patients can make your job easier.